SDGR - Schrodinger Inc-United States Stock Price, Fair Value and News

23.20USD-0.52 (-2.19%)Delayed as of 08 May 2024, 02:05 pm ET

Market Summary

USD23.20-0.52

Delayedas of 08 May 2024, 02:05 pm

-2.19%

SDGR Alerts

Big fall in Revenue (Y/Y)

Big fall in earnings (Y/Y)
Losses in recent quarter

SDGR Stock Price

View Fullscreen

SDGR RSI Chart

SDGR Valuation

Market Cap

1.7B

Price/Earnings (Trailing)

-11.98

Price/Sales (Trailing)

9.1

EV/EBITDA

-9.78

Price/Free Cashflow

-10.8

SDGR Price/Sales (Trailing)

SDGR Profitability

Operating Margin

60.42%

EBT Margin

-88.52%

Return on Equity

-27.86%

Return on Assets

-19.4%

Free Cashflow Yield

-9.26%

SDGR Fundamentals

SDGR Revenue

Revenue (TTM)

188.5M

Rev. Growth (Yr)

-43.51%

Rev. Growth (Qtr)

-50.63%

SDGR Earnings

Earnings (TTM)

-143.1M

Earnings Growth (Yr)

-142.38%

Earnings Growth (Qtr)

-78.43%

Breaking Down SDGR Revenue

52 Week Range

22.9359.24

(Low)(High)

Last 7 days

-2.7%

Last 30 days

-11.9%

Last 90 days

-10.3%

Trailing 12 Months

-14.5%

How does SDGR drawdown profile look like?

SDGR Financial Health

Current Ratio

4.64

SDGR Investor Care

Shares Dilution (1Y)

1.15%

Diluted EPS (TTM)

-1.97

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	188.5M	0	0	0
2023	197.1M	193.8M	199.4M	216.7M
2022	154.5M	163.2M	170.3M	181.0M
2021	114.0M	120.7M	124.8M	137.9M
2020	91.0M	95.1M	100.9M	108.1M
2019	0	0	0	85.5M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Schrodinger Inc-United States

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 06, 2024	lorton kenneth patrick	acquired	24,191	4.34	5,574	evp, cto & coo, software
Mar 04, 2024	porges geoffrey craig	acquired	-	-	9,000	evp & cfo
Mar 04, 2024	porges geoffrey craig	sold	-87,360	26.353	-3,315	evp & cfo
Mar 04, 2024	herman jenny	acquired	-	-	7,313	svp & controller
Feb 12, 2024	tran yvonne	sold	-21,443	28.29	-758	evp, clo & cpo
Feb 12, 2024	herman jenny	sold	-22,264	28.29	-787	svp & controller
Feb 12, 2024	abel robert lorne	sold	-33,197	27.55	-1,205	see remarks
Feb 12, 2024	lorton kenneth patrick	sold	-25,489	28.29	-901	evp, cto & coo, software
Sep 15, 2023	herman jenny	acquired	5,454	1.2	4,545	svp & controller
Aug 09, 2023	dugan margaret	acquired	-	-	15,000	chief medical officer

Which funds bought or sold SDGR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	DUALITY ADVISERS, LP	added	12.34	-267,274	1,482,160	0.15%
May 06, 2024	Advisory Services Network, LLC	reduced	-0.87	-105,969	313,929	0.01%
May 06, 2024	SG Americas Securities, LLC	sold off	-100	-183,000	-	-%
May 06, 2024	Integrated Advisors Network LLC	added	0.68	-1,270,780	4,008,390	0.20%
May 06, 2024	Quantbot Technologies LP	sold off	-100	-648,087	-	-%
May 06, 2024	Candriam S.C.A.	added	24.65	-304,830	4,779,000	0.03%
May 06, 2024	TEXAS PERMANENT SCHOOL FUND CORP	added	1.33	-398,836	1,292,460	0.01%
May 06, 2024	Parallel Advisors, LLC	added	104	891	2,538	-%
May 03, 2024	OREGON PUBLIC EMPLOYEES RETIREMENT FUND	reduced	-8.75	-178,600	394,200	0.01%
May 03, 2024	Householder Group Estate & Retirement Specialist, LLC	unchanged	-	-1,873	8,127	-%

Are Funds Buying or Selling SDGR?

Are funds buying SDGR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SDGR

No. of Funds

Unveiling Schrodinger Inc-United States's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	10.78%	6,776,631	SC 13G/A
Jan 23, 2024	blackrock inc.	13.9%	8,763,505	SC 13G/A
Jul 10, 2023	vanguard group inc	10.69%	6,669,820	SC 13G/A
Jul 07, 2023	blackrock inc.	13.5%	8,438,927	SC 13G/A
Feb 10, 2023	ark investment management llc	6.21%	3,852,037	SC 13G
Feb 09, 2023	vanguard group inc	8.25%	5,120,349	SC 13G/A
Feb 03, 2023	blackrock inc.	6.4%	3,956,805	SC 13G
Feb 09, 2022	blackrock inc.	5.0%	3,057,148	SC 13G/A
Feb 04, 2022	blackrock inc.	5.1%	3,123,673	SC 13G
Dec 01, 2021	shaw david e	3.9%	2,401,777	SC 13G/A

Recent SEC filings of Schrodinger Inc-United States

View All Filings

Date Filed	Form Type	Document
May 01, 2024	10-Q	Quarterly Report
May 01, 2024	8-K	Current Report
Apr 25, 2024	ARS	ARS
Apr 25, 2024	DEF 14A	DEF 14A
Apr 25, 2024	DEFA14A	DEFA14A
Apr 11, 2024	PRE 14A	PRE 14A
Mar 22, 2024	4	Insider Trading
Mar 22, 2024	4	Insider Trading
Mar 07, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading

Peers (Alternatives to Schrodinger Inc-United States)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	462.0B	371.6B	9.96%	1.73%	20.64	1.24	14.64%	11.24%
CI	98.5B	206.0B	-4.33%	31.01%	25.56	0.48	12.55%	-43.95%
HCA	82.4B	66.7B	-4.37%	13.20%	15.06	1.23	9.59%	-4.59%
CVS	70.0B	360.9B	-25.27%	-20.02%	9.55	0.19	9.07%	78.49%
CNC	40.5B	155.5B	4.29%	11.16%	14.81	0.26	6.34%	84.42%
DVA	12.1B	12.3B	3.05%	54.33%	14.8	0.98	5.77%	58.74%
UHS	11.7B	14.3B	-2.27%	18.37%	16.37	0.82	6.59%	6.24%
MID-CAP
CHE	8.8B	2.3B	-7.98%	4.98%	30.96	3.83	5.96%	18.29%
ACHC	6.3B	3.0B	-11.24%	-2.13%	-553.66	2.09	10.92%	-104.06%
AMN	2.3B	3.8B	3.83%	-33.34%	10.82	0.6	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.08%	8.52%	34.65	1.52	21.19%	34.42%
SMALL-CAP
ADUS	1.7B	1.1B	2.42%	25.02%	26.07	1.57	11.45%	30.74%
BKD	1.4B	3.0B	8.71%	84.46%	-7.37	0.46	6.74%	20.73%
BEAT	54.0M	-	-2.35%	-2.35%	-3.69	-	-	-12.94%
AMS	19.6M	21.3M	10.24%	15.77%	36.7	0.92	8.00%	-62.25%

Schrodinger Inc-United States News

Latest updates

Schrodinger Inc-United States Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-50.6%	36,598,000	74,126,000	42,569,000	35,189,000	64,782,000	56,843,000	36,980,000	38,469,000	48,663,000	46,170,000	29,850,000	29,784,000	32,127,000	33,032,000	25,797,000	23,092,000	26,174,000	25,832,000	19,960,000	19,010,000	20,741,000
Cost Of Revenue	6.8%	17,708,000	16,576,000	18,930,000	21,379,000	19,089,000	18,139,000	19,779,000	21,335,000	20,680,000	19,809,000	18,735,000	17,804,000	15,963,000	14,040,000	10,525,000	9,509,000	10,549,000	10,305,000	9,249,000	9,159,000	7,737,000
Gross Profit	-67.2%	18,890,000	57,550,000	23,639,000	13,810,000	45,693,000	38,704,000	17,201,000	17,134,000	27,983,000	26,361,000	11,115,000	11,980,000	16,164,000	18,992,000	15,272,000	13,583,000	15,625,000	15,527,000	10,711,000	9,851,000	13,004,000
Operating Expenses	-1.0%	86,323,000	87,171,000	79,832,000	74,943,000	76,194,000	67,242,000	63,364,000	60,607,000	56,626,000	48,876,000	45,789,000	42,322,000	40,076,000	35,576,000	30,717,000	30,670,000	27,425,000	23,374,000	22,003,000	23,814,000	18,617,000
S&GA Expenses	2.2%	10,171,000	9,950,000	9,109,000	9,022,000	9,145,000	9,382,000	7,161,000	7,428,000	6,671,000	5,975,000	5,556,000	5,380,000	5,239,000	4,675,000	3,969,000	4,362,000	4,789,000	5,743,000	5,185,000	5,343,000	5,093,000
R&D Expenses	-1.7%	50,611,000	51,487,000	46,833,000	42,705,000	40,741,000	34,542,000	32,885,000	31,123,000	27,822,000	25,145,000	23,219,000	21,092,000	21,448,000	17,319,000	17,019,000	16,657,000	13,700,000	11,082,000	10,353,000	9,531,000	8,438,000
EBITDA Margin	-483.3%	-0.86	0.22	0.26	0.40	0.23	-0.80	-0.87	-0.88	-0.85	-0.71	-0.63	-0.33	-0.08	-0.21	-0.18	-0.36	-0.34	-0.26	-	-	-
Income Taxes	154.2%	456,000	-842,000	-2,887,000	-20,431,000	26,359,000	-136,000	194,000	33,000	-28,000	274,000	-4,000	67,000	74,000	225,000	-35,000	64,000	91,000	-29,000	-257,000	-51,000	46,000
Earnings Before Taxes	-72.2%	-54,268,000	-31,512,000	-64,911,000	-16,153,000	155,495,000	-27,346,000	-39,659,000	-47,653,000	-34,468,000	-30,441,000	-35,015,000	-34,903,000	-449,000	-11,361,000	3,251,000	-4,002,000	-14,180,000	-7,174,000	-12,218,000	-778,000	-5,802,000
EBT Margin	-546.9%	-0.89	0.20	0.24	0.37	0.21	-0.82	-0.89	-0.90	-0.87	-0.73	-0.65	-0.36	-0.11	-0.24	-0.22	-0.40	-0.38	-0.30	-	-	-
Net Income	-78.4%	-54,724,000	-30,670,000	-62,024,000	4,278,000	129,136,000	-27,207,000	-39,853,000	-47,686,000	-34,440,000	-30,303,000	-35,007,000	-34,970,000	-523,000	-10,558,500	3,852,000	-4,066,000	-14,271,000	-6,628,500	-11,508,000	-727,000	-5,848,000
Net Income Margin	-504.1%	-0.76	0.19	0.22	0.34	0.07	-0.82	-0.89	-0.90	-0.87	-0.73	-0.65	-0.35	-0.10	-0.23	-0.21	-0.38	-0.36	-0.29	-	-	-
Free Cashflow	-9.2%	-43,371,000	-39,734,000	-54,858,000	-20,870,000	-34,674,000	-26,288,000	-33,361,000	-26,641,000	-41,407,000	-20,695,000	-13,421,000	-32,286,000	-11,434,000	42,732,000	-12,357,000	-9,535,000	-6,621,000	-11,422,000	-6,217,000	-4,568,000	-5,688,000

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																		(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Assets	-8.1%	738	803	794	842	839	689	662	688	720	756	763	717	744	746	680	350	350	155
Current Assets	-13.1%	494	568	548	592	604	534	524	557	586	625	622	650	675	683	621	307	313	119
Cash Equivalents	-13.2%	135	155	249	286	233	90.00	109	131	121	123	164	121	134	203	211	111	145	26.00
Net PPE	-	-	-	22.00	20.00	16.00	14.00	14.00	12.00	11.00	10.00	9.00	7.00	5.00	5.00	5.00	6.00	6.00	6.00
Goodwill	0%	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	-	-	-	-	-	-	-	-	-
Liabilities	-11.9%	224	254	231	230	249	241	199	195	189	199	183	112	112	122	49.00	53.00	54.00	57.00
Current Liabilities	-20.3%	107	134	105	107	123	109	89.00	86.00	86.00	91.00	73.00	70.00	68.00	73.00	39.00	43.00	42.00	45.00
Shareholder's Equity	-6.4%	514	549	564	611	590	448	463	493	531	557	580	606	632	624	631	296	296	-
Retained Earnings	-16.2%	-393	-338	-307	-245	-250	-379	-351	-312	-264	-229	-199	-164	-129	-129	-118	-122	-118	-105
Additional Paid-In Capital	2.3%	906	886	871	857	840	829	818	808	797	787	778	769	761	753	748	417	414	12.00
Shares Outstanding	14.8%	72.00	63.00	72.00	72.00	71.00	62.00	71.00	71.00	71.00	71.00	70.00	71.00	70.00	60.00	57.00	52.00	41.00	6.00
Minority Interest	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Float	-	-	-	-	1,759	-	-	-	1,288	-	-	-	3,519,899	-	-	-	2,187	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-5.4%	-39,276	-37,255	-49,941	-18,443	-31,094	-24,942	-30,363	-24,667	-39,711	-19,738	-10,638	-29,372	-10,921	43,618	-12,032	-9,051	-5,778	-11,265	-5,931	-4,240	-4,623
Share Based Compensation	-2.5%	12,218	12,534	12,654	11,773	10,880	10,205	9,864	10,427	9,134	7,456	7,652	7,016	4,366	3,003	3,038	2,729	1,775	581	561	531	520
Cashflow From Investing	108.5%	5,079	-59,614	13,203	67,243	172,202	11,557	7,840	34,322	36,304	-22,091	52,376	14,812	-61,909	-53,238	-215,983	-24,587	-87,913	6,377	-5,660	-38,495	-16,077
Cashflow From Financing	244.0%	8,005	2,327	1,330	4,524	867	482	324	396	908	1,217	1,442	1,637	3,656	1,426	328,125	-731	212,454	-1,715	226	25,007	5,166

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

SDGR Income Statement

2024-03-31

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Total revenues	$ 36,598	$ 64,782
Cost of revenues:
Total cost of revenues	17,708	19,089
Gross profit	18,890	45,693
Operating expenses:
Research and development	50,611	40,741
Sales and marketing	10,171	9,145
General and administrative	25,541	26,308
Total operating expenses	86,323	76,194
Loss from operations	(67,433)	(30,501)
Other income:
Gain on equity investments	0	147,322
Change in fair value	8,137	35,737
Other income	5,028	2,937
Total other income	13,165	185,996
(Loss) income before income taxes	(54,268)	155,495
Income tax expense	456	26,359
Net (loss) income	$ (54,724)	$ 129,136
Earnings Per Share [Abstract]
Net (loss) income per share of common and limited common stockholders, basic: (in USD per share)	$ (0.76)	$ 1.81
Weighted average shares used to compute net (loss) income per share of common and limited common stockholders, basic: (in shares)	72,291,134	71,467,097
Net (loss) income per share of common and limited common stockholders, diluted: (in USD per share)	$ (0.76)	$ 1.75
Weighted average shares used to compute net (loss) income per share of common and limited common stockholders, diluted: (in shares)	72,291,134	73,818,611
Software products and services
Revenues:
Total revenues	$ 33,415	$ 32,213
Cost of revenues:
Total cost of revenues	7,976	7,115
Drug discovery
Revenues:
Total revenues	3,183	32,569
Cost of revenues:
Total cost of revenues	$ 9,732	$ 11,974

SDGR Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 130,236	$ 155,315
Restricted cash	4,638	5,751
Marketable securities	300,843	307,688
Accounts receivable, net of allowance for doubtful accounts of $130 and $220	19,839	65,992
Unbilled and other receivables, net for allowance for unbilled receivables of $130 and $100	25,781	23,124
Prepaid expenses	12,349	9,926
Total current assets	493,686	567,796
Property and equipment, net	26,133	23,325
Equity investments	91,387	83,251
Goodwill	4,791	4,791
Right of use assets - operating leases	118,578	117,778
Other assets	3,187	6,014
Total assets	737,762	802,955
Current liabilities:
Accounts payable	9,974	16,815
Accrued payroll, taxes, and benefits	19,549	31,763
Deferred revenue	49,497	56,231
Lease liabilities - operating leases	16,927	16,868
Other accrued liabilities	10,560	11,996
Total current liabilities	106,507	133,673
Deferred revenue, long-term	8,016	9,043
Lease liabilities - operating leases, long-term	108,988	111,014
Other liabilities, long-term	545	667
Total liabilities	224,056	254,397
Commitments and contingencies (Note 5)
Stockholders' equity:
Preferred stock, $0.01 par value. Authorized 10,000,000 shares; zero shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	0	0
Additional paid-in capital	906,193	885,973
Accumulated deficit	(393,142)	(338,418)
Accumulated other comprehensive (loss) income	(72)	281
Total stockholders' equity	513,706	548,558
Total liabilities and stockholders' equity	737,762	802,955
Common Stock
Stockholders' equity:
Common and Limited Stock	635	630
Limited common stock
Stockholders' equity:
Common and Limited Stock	$ 92	$ 92

About Schrodinger Inc-United States

SchrÃƒÂ¶dinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. SchrÃƒÂ¶dinger, Inc. was incorporated in 1990 and is based in New York, New York.

CEO	Dr. Ramy Farid Ph.D.
WEBSITE	schrodinger.com
INDUSTRY	Healthcare Plans
EMPLOYEES	787

Schrodinger Inc-United States Frequently Asked Questions

What is the ticker symbol for Schrodinger Inc-United States? What does SDGR stand for in stocks?

SDGR is the stock ticker symbol of Schrodinger Inc-United States. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Schrodinger Inc-United States (SDGR)?

As of Tue May 07 2024, market cap of Schrodinger Inc-United States is 1.71 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SDGR stock?

You can check SDGR's fair value in chart for subscribers.

What is the fair value of SDGR stock?

You can check SDGR's fair value in chart for subscribers. The fair value of Schrodinger Inc-United States is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Schrodinger Inc-United States is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SDGR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Schrodinger Inc-United States a good stock to buy?

The fair value guage provides a quick view whether SDGR is over valued or under valued. Whether Schrodinger Inc-United States is cheap or expensive depends on the assumptions which impact Schrodinger Inc-United States's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SDGR.

What is Schrodinger Inc-United States's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, SDGR's PE ratio (Price to Earnings) is -11.98 and Price to Sales (PS) ratio is 9.1. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SDGR PE ratio will change depending on the future growth rate expectations of investors.